DK0607777T3 - Anvendelse af leflunomid til inhibering af interleukin 8 - Google Patents
Anvendelse af leflunomid til inhibering af interleukin 8Info
- Publication number
- DK0607777T3 DK0607777T3 DK94100017T DK94100017T DK0607777T3 DK 0607777 T3 DK0607777 T3 DK 0607777T3 DK 94100017 T DK94100017 T DK 94100017T DK 94100017 T DK94100017 T DK 94100017T DK 0607777 T3 DK0607777 T3 DK 0607777T3
- Authority
- DK
- Denmark
- Prior art keywords
- leflunomide
- inhibit interleukin
- interleukin
- inhibit
- methylisoxazole
- Prior art date
Links
- 102000004890 Interleukin-8 Human genes 0.000 title abstract 2
- 108090001007 Interleukin-8 Proteins 0.000 title abstract 2
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 title abstract 2
- 229940096397 interleukin-8 Drugs 0.000 title abstract 2
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000681 leflunomide Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4300278 | 1993-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0607777T3 true DK0607777T3 (da) | 1999-08-16 |
Family
ID=6477854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94100017T DK0607777T3 (da) | 1993-01-08 | 1994-01-03 | Anvendelse af leflunomid til inhibering af interleukin 8 |
Country Status (8)
Country | Link |
---|---|
US (1) | US5547971A (da) |
EP (1) | EP0607777B1 (da) |
JP (1) | JPH06234636A (da) |
AT (1) | ATE174220T1 (da) |
DE (1) | DE59407415D1 (da) |
DK (1) | DK0607777T3 (da) |
ES (1) | ES2125356T3 (da) |
GR (1) | GR3029489T3 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
DE59800287D1 (de) * | 1997-08-08 | 2000-11-09 | Aventis Pharma Gmbh | Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid |
US7051557B2 (en) * | 2002-07-18 | 2006-05-30 | Sara Lee Corporation | Hidden band brassiere, blank and methods of making same |
AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
WO2022128054A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
AU649421B2 (en) * | 1990-05-18 | 1994-05-26 | Sanofi-Aventis Deutschland Gmbh | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs |
-
1994
- 1994-01-03 DE DE59407415T patent/DE59407415D1/de not_active Expired - Lifetime
- 1994-01-03 DK DK94100017T patent/DK0607777T3/da active
- 1994-01-03 AT AT94100017T patent/ATE174220T1/de active
- 1994-01-03 ES ES94100017T patent/ES2125356T3/es not_active Expired - Lifetime
- 1994-01-03 EP EP94100017A patent/EP0607777B1/de not_active Expired - Lifetime
- 1994-01-07 JP JP6000400A patent/JPH06234636A/ja not_active Withdrawn
-
1995
- 1995-03-28 US US08/411,848 patent/US5547971A/en not_active Expired - Lifetime
-
1999
- 1999-02-25 GR GR990400585T patent/GR3029489T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5547971A (en) | 1996-08-20 |
EP0607777B1 (de) | 1998-12-09 |
GR3029489T3 (en) | 1999-05-28 |
ATE174220T1 (de) | 1998-12-15 |
EP0607777A3 (da) | 1994-08-31 |
DE59407415D1 (de) | 1999-01-21 |
JPH06234636A (ja) | 1994-08-23 |
ES2125356T3 (es) | 1999-03-01 |
EP0607777A2 (de) | 1994-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0607775T3 (da) | Anvendelse af leflunomid til inhibering af interleukin 1 beta | |
ATE156482T1 (de) | 1,4,5-triphenyl-pyrazolverbindungen zur behandlumg von entzündungen und entzündungsverwandten störungen | |
DE69334250D1 (de) | Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern | |
DK0607776T3 (da) | Anvendelse af leflunomid til inhibering af tumornekrosefaktor alfa | |
DE122006000010I1 (de) | Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten | |
FI935778A (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten | |
PT809636E (pt) | Isoxazoles substituidos utilizaveis para o tratamento de inflamacoes | |
FI935585A0 (fi) | Pyrrolopyrimidiner | |
KR100344712B1 (ko) | 알러지성및염증성질환의치료에유용한화합물 | |
ATE63906T1 (de) | 3,5-disubstituierte 4,5-dihydroisoxazole als transglutaminasehemmer. | |
DK0607777T3 (da) | Anvendelse af leflunomid til inhibering af interleukin 8 | |
ES2106531T3 (es) | Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso. | |
ATE124681T1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
MD960168A (ro) | Metodă şi compuşi pentru tratamentul infecţiilor virale | |
DK0607774T3 (da) | Anvendelse af leflunomid til inhibering af interleukin 1 alfa | |
DK149590C (da) | Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser | |
DE3864124D1 (de) | Isoxazole mit nootropischer wirkung. | |
PT77378A (de) | 2-phenoxypropionsaeurederivate von pentiten verfahren zur hers-tellung dieser verbindungen sowie diese enthaltende mittel mit herbizider wirkung | |
SE9201188D0 (sv) | Ny anvaendning | |
DE69026991D1 (de) | Phospholipide zur Behandlung der multiplen Sklerose | |
DE3684825D1 (de) | Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit. | |
SU1732643A1 (ru) | Амиды n-этоксиоксалилантраниловой кислоты, проявляющие противовоспалительную и анальгетическую активность |